Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
A variety of human and animal studies support the hypothesis that serotonin (5-hydroxytryptamine or 5-HT) system dysfunction is a contributing factor to the development of autism in some patients. However, many questions remain about how developmental manipulation of various components that influence 5-HT signaling (5-HT synthesis, transport, metabolism) persistently impair social behaviors. This review will summarize key aspects of central 5-HT function important for normal brain development, and review evidence implicating perinatal disruptions in 5-HT signaling in the pathophysiology of autism spectrum disorder. We discuss the importance, and relative dearth, of studies that explore the possible correlation to autism in the interactions between important intrinsic and extrinsic factors that may disrupt 5-HT homeostasis during development. In particular, we focus on exposure to 5-HT transport altering mechanisms such as selective serotonin-reuptake inhibitors or genetic polymorphisms in primary or auxiliary transporters of 5-HT, and how they relate to neurological stores of serotonin and its precursors. A deeper understanding of the many mechanisms by which 5-HT signaling can be disrupted, alone and in concert, may contribute to an improved understanding of the etiologies and heterogeneous nature of this disorder. We postulate that extreme bidirectional perturbations of these factors during development likely compound or synergize to facilitate enduring neurochemical changes resulting in insufficient or excessive 5-HT signaling, that could underlie the persistent behavioral characteristics of autism spectrum disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Christensen, D. L., Baio, J., Braun, K. V. N., Bilder, D., Charles, J., Constantino, J. N., Daniels, J., Durkin, M. S., Fitzgerald, R. T., Kurzius-Spencer, M., et al. (2016) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6503a1 · Cited by 1,964
RetractedChristensen, D. L., Braun, K. V. N., Baio, J., Bilder, D., Charles, J., Constantino, J. N., Daniels, J., Durkin, M. S., Fitzgerald, R. T., Kurzius-Spencer, M., et al. (2018) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6513a1 · Cited by 587
RetractedBaio, J., Wiggins, L., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., Kurzius-Spencer, M., Zahorodny, W., Robinson, C., Rosenberg, et al. (2018) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6706a1 · Cited by 6,078
Allelic Variation of Human Serotonin Transporter Gene Expression
Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062621.x · Cited by 2,221
Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821 · cited 1×
“These babies may experience long-term impacts on 5-HT neurotransmission [169], though extensive, longitudinal studies are needed to evaluate this possibility.”
The health status of adults on the autism spectrum
Croen, L. A., Zerbo, O., Qian, Y., Massolo, M. L., Rich, S., Sidney, S., & Kripke, C. (2015) · Autism · doi:10.1177/1362361315577517 · Cited by 1,110
Long story short: the serotonin transporter in emotion regulation and social cognition
Canli, T., & Lesch, K.-P. (2007) · Nature Neuroscience · doi:10.1038/nn1964 · Cited by 1,034 · cited 1×
“4–2 fold) SERT in the dorsal raphe, a locus of 5-HT neuronal cell bodies that project extensively to the forebrain [117].”
Defining the social deficits of autism: the contribution of non-verbal communication measures
Mundy, P., Sigman, M., Ungerer, J., & Sherman, T. (1986) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1986.tb00190.x · Cited by 956
A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay
Girirajan, S., Rosenfeld, J. A., Cooper, G. M., Antonacci, F., Siswara, P., Itsara, A., Vives, L., Walsh, T., McCarthy, S. E., Baker, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.534 · Cited by 667
A transient placental source of serotonin for the fetal forebrain
Bonnin, A., Goeden, N., Chen, K., Wilson, M. L., King, J., Shih, J. C., Blakely, R. D., Deneris, E. S., & Levitt, P. (2011) · Nature · doi:10.1038/nature09972 · Cited by 608 · cited 5×
“5-HT immunoreactive cells and fibers develop early in embryogenesis (embryonic day (ED) 12 in rodents and by 5 weeks gestation in humans) [38,40].”
InfluentialYoshida, M., Takayanagi, Y., Inoue, K., Kimura, T., Young, L. J., Onaka, T., & Nishimori, K. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5593-08.2009 · Cited by 608
Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children
Schain, R. J., & Freedman, D. X. (1961) · The Journal of Pediatrics · doi:10.1016/s0022-3476(61)80261-8 · Cited by 579 · cited 1×
“Perhaps though, the most convincing evidence emerged in 1961, when it was discovered that 6% of a group of autistic patients demonstrated hyperserotonemia [57], a condition of high platelet 5-HT content, putatively a consequence of increased 5-HT uptake through SERT.”
The serotonin system in autism spectrum disorder: From biomarker to animal models
Muller, C. L., Anacker, A. M. J., & Veenstra-VanderWeele, J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.010 · Cited by 531 · cited 1×
“These variants produce a gain of SERT functionality, accelerating 5-HT uptake from extracellular fluid and, in the blood, concentrating 5-HT into platelets and producing hyperserotonemia [49,55,79,114,127].”
Antidepressant Use During Pregnancy and Childhood Autism Spectrum Disorders
Croen, L. A. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.73 · Cited by 510
Serotonin and brain development: role in human developmental diseases
Whitaker-Azmitia, P. M. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00615-3 · Cited by 506
The role of the hippocampus in flexible cognition and social behavior
Rubin, R. D., Watson, P. D., Duff, M. C., & Cohen, N. J. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00742 · Cited by 489
Targeting the murine serotonin transporter: insights into human neurobiology
Murphy, D. L., & Lesch, K.-P. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2284 · Cited by 478
VOLKMAR, F. R., & NELSON, D. S. (1990) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199001000-00020 · Cited by 439 · cited 1×
“fundamental scope of an ASD diagnosis including: communication impairments [6], seizures [7,8], anxiety [9,10], mood disorders [11], hyperactivity [12], sleep deficits [13], and attention deficit disorders [14].”
Lesch, K.-P., & Waider, J. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.013 · Cited by 435
Leblond, C. S., Heinrich, J., Delorme, R., Proepper, C., Betancur, C., Huguet, G., Konyukh, M., Chaste, P., Ey, E., Rastam, M., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002521 · Cited by 429 · cited 2×
“These studies suggest that “uptake 2” mechanisms, putatively OCT3, may play a significant role in 5-HT signaling and homeostasis, particularly when SERT function is reduced [147,152,153].”
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
Williams, K., Brignell, A., Randall, M., Silove, N., & Hazell, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004677.pub3 · Cited by 415
Association of Maternal Diabetes With Autism in Offspring
Xiang, A. H., Wang, X., Martinez, M. P., Walthall, J. C., Curry, E. S., Page, K., Buchanan, T. A., Coleman, K. J., & Getahun, D. (2015) · JAMA · doi:10.1001/jama.2015.2707 · Cited by 395
Sutcliffe, J. S., Delahanty, R. J., Prasad, H. C., McCauley, J. L., Han, Q., Jiang, L., Li, C., Folstein, S. E., & Blakely, R. D. (2005) · The American Journal of Human Genetics · doi:10.1086/432648 · Cited by 392 · cited 3×
“SLC6A4 Gly56Ala hyperfunctional SERT uptake [24] Ala56 ✔ ✔ [79,97]”
Rai, D., Lee, B. K., Dalman, C., Golding, J., Lewis, G., & Magnusson, C. (2013) · BMJ · doi:10.1136/bmj.f2059 · Cited by 365
Blood serotonin levels in autism spectrum disorder: A systematic review and meta-analysis
Gabriele, S., Sacco, R., & Persico, A. M. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.02.004 · Cited by 346 · cited 3×
“in both whole blood and platelet-rich plasma, but not in platelet-poor plasma (free), suggesting that 5-HT levels have the potential to be a biomarker at least in some cases of ASD [63].”
Veenstra-VanderWeele, J., Muller, C. L., Iwamoto, H., Sauer, J. E., Owens, W. A., Shah, C. R., Cohen, J., Mannangatti, P., Jessen, T., Thompson, B. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112345109 · Cited by 333
Self-citationSerotonin: a regulator of neuronal morphology and circuitry
Daubert, E. A., & Condron, B. G. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.05.005 · Cited by 326
Neurochemical correlates of autistic disorder: a review of the literature
Lam, K. S. L., Aman, M. G., & Arnold, L. E. (2006) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2005.03.003 · Cited by 318 · cited 1×
“The 5-HT hypothesis of ASD emerged from a large, though still contentious body of evidence observing 5-HT abnormalities in individuals with an ASD diagnosis (reviewed in more detail in [56]).”
Bonnin, A., & Levitt, P. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.005 · Cited by 311
Bakker, J., De Mees, C., Douhard, Q., Balthazart, J., Gabant, P., Szpirer, J., & Szpirer, C. (2006) · Nature Neuroscience · doi:10.1038/nn1624 · Cited by 305 · cited 1×
“Alternatively, OCT3 has been shown to be inhibited by estradiol as well [158], and may help to explain the disparity in ASD incidence between males and females, and may even exacerbate symptoms in hyposerotonemia populations, given that males have high levels of brain estradiol during development [159,160].”
Effects of tryptophan depletion in drug-free adults with autistic disorder
McDougle, C. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830110029004 · Cited by 301
Antidepressant use during pregnancy and the risk of autism spectrum disorder in children
Boukhris, T., Sheehy, O., Mottron, L., & Bérard, A. (2016) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2015.3356 · Cited by 297
Autism spectrum disorder in fragile X syndrome: cooccurring conditions and current treatment
Kaufmann, W. E., Kidd, S. A., Andrews, H. F., Budimirovic, D. B., Esler, A., Haas-Givler, B., Stackhouse, T., Riley, C., Peacock, G., Sherman, S. L., et al. (2017) · PEDIATRICS · doi:10.1542/peds.2016-1159f · Cited by 268 · cited 1×
“fundamental scope of an ASD diagnosis including: communication impairments [6], seizures [7,8], anxiety [9,10], mood disorders [11], hyperactivity [12], sleep deficits [13], and attention deficit disorders [14].”
Social approach in genetically engineered mouse lines relevant to autism
Moy, S. S., Nadler, J. J., Young, N. B., Nonneman, R. J., Grossman, A. W., Murphy, D. L., D’Ercole, A. J., Crawley, J. N., Magnuson, T. R., & Lauder, J. M. (2009) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2008.00452.x · Cited by 246
Sujan, A. C., Rickert, M. E., Öberg, A. S., Quinn, P. D., Hernández-Díaz, S., Almqvist, C., Lichtenstein, P., Larsson, H., & D’Onofrio, B. M. (2017) · JAMA · doi:10.1001/jama.2017.3413 · Cited by 226
Hollander, E., Soorya, L., Chaplin, W., Anagnostou, E., Taylor, B. P., Ferretti, C. J., Wasserman, S., Swanson, E., & Settipani, C. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10050764 · Cited by 224 · cited 2×
“For example, only a minority (approximately 35%) of children and adolescents [132] with ASD exhibit reduced irritability, stereotypies, and inappropriate speech and hyperactivity when receiving SSRI treatment [132–135].”
The reciprocal interaction between serotonin and social behaviour
Kiser, D., SteemerS, B., Branchi, I., & Homberg, J. R. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.009 · Cited by 214
Malm, H., Brown, A. S., Gissler, M., Gyllenberg, D., Hinkka-Yli-Salomäki, S., McKeague, I. W., Weissman, M., Wickramaratne, P., Artama, M., Gingrich, J. A., et al. (2016) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2016.02.013 · Cited by 206
Clements, C. C., Castro, V. M., Blumenthal, S. R., Rosenfield, H. R., Murphy, S. N., Fava, M., Erb, J. L., Churchill, S. E., Kaimal, A. J., Doyle, A. E., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.90 · Cited by 197
Role of the serotonin transporter gene in the behavioral expression of autism
Tordjman, S., Gutknecht, L., Carlier, M., Spitz, E., Antoine, C., Slama, F., Carsalade, V, Cohen, D. J., Ferrari, P., Roubertoux, P. L., et al. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000873 · Cited by 196 · cited 2×
“Recent studies have indicated that genotypes with at least one short allele are more prevalent in children with ASD as compared to healthy controls [21,95,121].”
Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism
Hviid, A., Melbye, M., & Pasternak, B. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301449 · Cited by 195
Leboyer, M., Philippe, A., Bouvard, M., Guilloud-Bataille, M., Bondoux, D., Tabuteau, F., Feingold, J., Mouren-Simeoni, M.-C., & Launay, J.-M. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00532-5 · Cited by 194 · cited 1×
“In addition to the accepted biomarker of hyperserotonemia [60,61,63], TRP insuffiency has emerged as a possible indicative marker for ASD as well.”
Co-occurrence of ADHD and autism spectrum disorders: phenomenology and treatment
Reiersen, A. M., & Todd, R. D. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.4.657 · Cited by 189 · cited 1×
“fundamental scope of an ASD diagnosis including: communication impairments [6], seizures [7,8], anxiety [9,10], mood disorders [11], hyperactivity [12], sleep deficits [13], and attention deficit disorders [14].”
Carneiro, A. M. D., Cook, E. H., Murphy, D. L., & Blakely, R. D. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33374 · Cited by 180
Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay
Harrington, R. A., Lee, L.-C., Crum, R. M., Zimmerman, A. W., & Hertz-Picciotto, I. (2014) · Pediatrics · doi:10.1542/peds.2013-3406 · Cited by 174
Serotonin and dopamine transporter binding in children with autism determined by SPECT
Makkonen, I., Riikonen, R., Kokki, H., Airaksinen, M. M., & Kuikka, J. T. (2008) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2008.03027.x · Cited by 169
The serotonin-N-acetylserotonin-melatonin pathway as a biomarker for autism spectrum disorders
Pagan, C., Delorme, R., Callebert, J., Goubran-Botros, H., Amsellem, F., Drouot, X., Boudebesse, C., Le Dudal, K., Ngo-Nguyen, N., Laouamri, H., et al. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.120 · Cited by 165 · cited 1×
“Further candidate contributors, beyond the scope of this review, are melatonin and kynurenine metabolic pathways for which TRP is also the precursor [235].”
Antidepressant exposure in pregnancy and risk of autism spectrum disorders
Sorensen, M. J., Christensen, J., Parner, E. T., Grønborg, T. K., Vestergaard, M., Schendel, D., & Pedersen, L. H. (2013) · Clinical Epidemiology · doi:10.2147/clep.s53009 · Cited by 163
Glatt, C. E., DeYoung, J. A., Delgado, S., Service, S. K., Giacomini, K. M., Edwards, R. H., Risch, N., & Freimer, N. B. (2001) · Nature Genetics · doi:10.1038/86948 · Cited by 154
Narboux-Nême, N., Pavone, L. M., Avallone, L., Zhuang, X., & Gaspar, P. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.020 · Cited by 148 · cited 3×
“SERT is a major regulator of this essential 5HT signaling during neurodevelopment [41], and is transiently expressed on non-serotonergic neurons in early life, facilitating organization of neuronal projections by regulating the duration of 5-HT signaling [28].”
Brown, H. K., Ray, J. G., Wilton, A. S., Lunsky, Y., Gomes, T., & Vigod, S. N. (2017) · JAMA · doi:10.1001/jama.2017.3415 · Cited by 143
Yang, C.-J., Tan, H.-P., & Du, Y.-J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.02.021 · Cited by 132 · cited 2×
“Decreases in 5-HT uptake (platelet hyposerotonemia) can also lead to deficits in neuronal network formation, given the critical neurodevelopmental role of 5-HT, and may also contribute to the pathophysiology of ASD [65].”
Man, K. K. C., Tong, H. H. Y., Wong, L. Y. L., Chan, E. W., Simonoff, E., & Wong, I. C. K. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.11.020 · Cited by 126
Marroun, H. E., White, T. J. H., van der Knaap, N. J. F., Homberg, J. R., Fernández, G., Schoemaker, N. K., Jaddoe, V. W. V., Hofman, A., Verhulst, F. C., Hudziak, J. J., et al. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.127746 · Cited by 117
In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder
Gidaya, N. B., Lee, B. K., Burstyn, I., Yudell, M., Mortensen, E. L., & Newschaffer, C. J. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-014-2128-4 · Cited by 115
Diverse effects of gut-derived serotonin in intestinal inflammation
Shajib, M. S., Baranov, A., & Khan, W. I. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00414 · Cited by 109
Wan, H., Zhang, C., Li, H., Luan, S., & Liu, C. (2018) · Medicine · doi:10.1097/md.0000000000009438 · Cited by 105
Nutritional status of children with Autism Spectrum Disorders (ASDs): A case—Control study
Marí-Bauset, S., Llopis-González, A., Zazpe-García, I., Marí-Sanchis, A., & Morales-Suárez-Varela, M. (2015) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-014-2205-8 · Cited by 87 · cited 1×
“Knowing TRP insufficiency might exacerbate ASD symptoms should particularly be considered in circumstances where the individual exhibits rigid food selectivity, and may be nutritionally deprived of critical dietary components such as TRP [206].”
Andalib, S., Emamhadi, M. R., Yousefzadeh-Chabok, S., Shakouri, S. K., Høilund-Carlsen, P. F., Vafaee, M. S., & Michel, T. M. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2017.06.001 · Cited by 86
Castro, V. M., Kong, S. W., Clements, C. C., Brady, R., Kaimal, A. J., Doyle, A. E., Robinson, E. B., Churchill, S. E., Kohane, I. S., & Perlis, R. H. (2016) · Translational Psychiatry · doi:10.1038/tp.2015.190 · Cited by 82
Autism risk following antidepressant medication during pregnancy
Viktorin, A., Uher, R., Reichenberg, A., Levine, S. Z., & Sandin, S. (2017) · Psychological Medicine · doi:10.1017/s0033291717001301 · Cited by 62
Ackerman, S., Schoenbrun, S., Hudac, C., & Bernier, R. (2017) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-017-3246-6 · Cited by 12
Cited by
Genetic Causes and Modifiers of Autism Spectrum Disorder
Rylaarsdam, L., & Guemez-Gamboa, A. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00385 · Cited by 560
Neurological disorders in autism: A systematic review and meta-analysis
Pan, P.-Y., Bölte, S., Kaur, P., Jamil, S., & Jonsson, U. (2021) · Autism · doi:10.1177/1362361320951370 · Cited by 83
Role of the Serotonin Receptor 7 in Brain Plasticity: From Development to Disease
(2020) · doi:10.3390/ijms21020505 · Cited by 63
Benachenhou, S., Etcheverry, A., Galarneau, L., Dubé, J., & Çaku, A. (2019) · Autism Research · doi:10.1002/aur.2183 · Cited by 33
Serotonergic neuromodulation of synaptic plasticity
Higa, G. S. V., Viana, F. J. C., Francis-Oliveira, J., Cruvinel, E., Franchin, T. S., Marcourakis, T., Ulrich, H., & De Pasquale, R. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110036 · Cited by 29
Metadata
- Authors
- Garbarino, V. R., Gilman, T. L., Daws, L. C., & Gould, G. G.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 140
- Pages
- 85-99
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W2884638905
- Cited by
- 85
- References
- 62
- FWCI
- 5.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.